We are delighted to invite you to the next meeting of the Christ’s College Life Sciences Network, taking place on Thursday 25 June.
The event will take place at the London offices of Kilburn & Strode, at Lacon House on Theobalds Road in Holborn. Talks will begin at 7pm with drinks and networking afterwards.
The network aims to connect alumni, postgraduate students and the broader College community who are interested in the field of life sciences, which has seen huge activity and tremendous breakthroughs over the last decade.
Speakers will include Dr Cat Donaldson and Dr Duncan Boanas-Evans (both Christ's m. 2005). Please find more information on the contributors below:
Dr Cat Donaldson
Cat Donaldson is Head of Corporate Development & Operations at Nilo Therapeutics in NYC, where she works at the intersection of science, strategy, and company building. She has more than a decade of experience spanning biotechnology investing, business development, and operational leadership across the life sciences ecosystem.
Prior to joining Nilo, Cat was Principal at Alexandria Venture Investments and Head of Alexandria LaunchLabs NYC, where she led investments, scouting, and operational support for early-stage life science companies. Earlier in her career, she served as Chief Development Officer at Cold Spring Harbor Laboratory, overseeing strategic partnerships, business development, and major fundraising initiatives.
Cat studied Natural Sciences at Christ's. She holds a PhD in Biochemistry from the University of Cambridge and an MBA in Healthcare Management.
Dr Duncan Boanas-Evans
Duncan Boanas-Evans is Executive Director, Patent Counsel at Eli Lilly and Company, where he leads patent strategy across a portfolio of pharmaceutical innovations. A European and Chartered UK Patent Attorney, Duncan brings expertise in biotechnology patent law, with particular focus on immunology, vaccines, antibodies, and RNA technology.
Duncan read Natural Sciences at Christ's College, graduating in 2009 with a BA/MSci in Biochemistry. He went on to complete a PhD at Imperial College's MRC Clinical Sciences Centre, investigating intracellular signalling pathways under Professor David Carling.